bupropion
- Product NDC
- 71205-565
- 11-digit product format
- 712050565
- Labeler code
- 71205
- Product ID
- 71205-565_64c33202-1fb1-4e0a-ae72-146375fa81aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA202304
- Marketing category
- ANDA
- Marketing start
- 2014-11-01
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202304-001 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | |
| A202304-002 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | |
| A202304-003 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202304-001 | AB1 |
| A202304-002 | AB1 |
| A202304-003 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202304-001 | BUPROPION HYDROCHLORIDE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202304-002 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202304-003 | BUPROPION HYDROCHLORIDE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB1 | 2015-05-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202304-001 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202304-002 | AB1 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202304-003 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bupropion hydrochloride SR | BUPROPION HYDROCHLORIDE | Major Pharmaceuticals | 67b6bcf8-0e7c-4e74-ad72-54f1bd6e65ad | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion hydrochloride SR | BUPROPION HYDROCHLORIDE | Cardinal Health 107, LLC | 439a7e93-f578-434f-943f-4b93c35450f5 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion hydrochloride SR | BUPROPION HYDROCHLORIDE | Solco Healthcare US LLC | 39b2d509-1281-4464-9cf1-a94bbc18b84b | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion hydrochloride SR | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 850ac56a-ba50-4e61-b1ee-805e17735b5c | 2026-03-20 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion | BUPROPION HYDROCHLORIDE | Northwind Health Company, LLC | ab6cd2ea-507c-35e5-e053-2a95a90ac5cb | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | DIRECT RX | 96d87edc-d12b-44b2-e053-2995a90a4e63 | 2025-01-22 | Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 7ded4fa6-e637-4d59-a1b1-286854d4fe3a | 2024-08-09 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 |
| bupropion | BUPROPION HYDROCHLORIDE | Proficient Rx LP | 909204fc-ff55-43d9-b9ee-e607ef60965e | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 202304 ANDA202304 71205-565 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- bupropion
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BUPROPION HYDROCHLORIDE | 150 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| ZG7E5POY8O | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 993518 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 909204fc-ff55-43d9-b9ee-e607ef60965e | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4eceb285-f3c7-4092-a21a-4c9f3169f20c | Product name | 5 | 20260220 |
| 548ba7fd-fd0c-4a21-b2b0-d01bf93143b8 | Product name | 3 | 20240209 |
| 43a1ed49-eae2-4840-8075-cb4b33478540 | Product name | 1 | 20230425 |
| b8ee525f-67fb-39fb-91da-7e47ac54581d | Product name | 5 | 20200611 |
| 98e65af1-f5d0-75d5-c930-f8a4ce4c3284 | Product name | 9 | 20190211 |
| e4d463bc-c674-43cb-be06-82786f310d01 | Product name | 1 | 20150326 |
| 0916dcfb-331f-89b1-8eac-6f7dc76d82da | Product name | 1 | 20140508 |
| d7fc3d53-5a6c-de82-2808-1780f175f17e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71205-565-30 | bupropion | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 2 | |
| 71205-565-60 | bupropion | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 2 | |
| 71205-565-90 | bupropion | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71205-565-30 | EA - Each | 71205-565 | 4eb397ba-a518-42d3-801c-ccc7ec782036 | 1 | 2021-10-08 |
| 71205-565-60 | EA - Each | 71205-565 | bd461bda-ffd8-466e-b44e-0617d31435a5 | 1 | 2021-07-15 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 993518 | buPROPion HCl 150 MG 12HR Extended Release Oral Tablet | PSN | 909204fc-ff55-43d9-b9ee-e607ef60965e | 2 |
| 993518 | 12 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet | SCD | 909204fc-ff55-43d9-b9ee-e607ef60965e | 2 |
| 993518 | bupropion HCl 150 MG 12 HR Extended Release Oral Tablet | SY | 909204fc-ff55-43d9-b9ee-e607ef60965e | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71205-565-30 | 71205056530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-565-30) | 2021-05-11 | 0000-00-00 | No | No | Current |
| 71205-565-60 | 71205056560 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-565-60) | 2021-05-11 | 0000-00-00 | No | No | Current |
| 71205-565-90 | 71205056590 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-565-90) | 2021-05-11 | 0000-00-00 | No | No | Current |